Excitotoxity and the NMDA receptor

doi:10.1016/0166-2236(87)90177-9

Trends in Neurosciences

Volume 10, Issue 7, July 1987, Pages 299-302

https://doi.org/10.1016/0166-2236(87)90177-9 Get rights and content

Abstract

The same receptors for excitatory amino acids (EAA) that mediate direct neuronal depolarization can also be responsible for neuronal injury. Prolonged stimulation of EAA receptors of either the $N- methyl- d -aspartate$ (NMDA) or non-NMDA types eventually results in the death of most central neurons. The exact mechanism(s) of cell injury is complicated, since depolarization and neuronal swelling, calcium influx, and possibly second messengers all contribute. Evidence is accumulating that the brain damage associated with anoxia, stroke, hypoglycemia, epilepsy, and perhaps neurodegenerative illnesses such as Huntington's disease may be at least partially produced by excessive activation of NMDA receptors. To the extent that the pathophysiology can be explained by this mechanism, it may be amenable to rational therapies now under development.

References (43)

J.W. Olney et al.
Brain Res.
(1981)
J.W. Olney et al.
Neurosci. Lett.
(1986)
F. Hajos et al.
Neuroscience
(1986)
G. Garthwaite et al.
Neuroscience
(1986)
J. Garthwaite et al.
Neuroscience
(1986)
R.S. Sloviter
Brain Res. Bull.
(1983)
P.S. Spencer et al.
Lancet
(1986)
D.R. Lucas et al.
AMA Arch. Ophthalmol.
(1957)
J.W. Olney
Science
(1969)
J.W. Olney et al.
Exp. Brain Res.
(1971)

J.W. Olney

J.C. Watkins et al.

J.W. Olney et al.

Neurosci. Lett.

(1986)

S.M. Rothman

J. Neurosci.

(1985)

D.W. Choi et al.

J. Neurosci.

(1987)

D.W. Choi

J. Neurosci.

(1987)

Rothman, S. M., Thurston, J. G. and Hauhart, R. E. Neuroscience (in...

J. Garthwaite et al.

Neurosci. Lett.

(1986)

A.B. MacDermott et al.

Nature

(1986)

J.L. Farber et al.

Am. J. Pathol.

(1981)

D.W. Choi et al.

Soc. Neurosci. Abstr.

(1986)

Cited by (1185)

MultiSimNeNc: A network representation learning-based module identification method by network embedding and clustering
2023, Computers in Biology and Medicine
Accurate identification of gene modules based on biological networks is an effective approach to understanding gene patterns of cancer from a module-level perspective. However, most graph clustering algorithms just consider low-order topological connectivity, which limits their accuracy in gene module identification. In this study, we propose a novel network-based method, MultiSimNeNc, to identify modules in various types of networks by integrating network representation learning (NRL) and clustering algorithms. In this method, we first obtain the multi-order similarity of the network using graph convolution (GC). Then, we aggregate the multi-order similarity to characterize the network structure and use non-negative matrix factorization (NMF) to achieve low-dimensional node characterization. Finally, we predict the number of modules based on the bayesian information criterion (BIC) and use the gaussian mixture model (GMM) to identify modules. To testify to the efficacy of MultiSimeNc in module identification, we apply this method to two types of biological networks and six benchmark networks, where the biological networks are constructed based on the fusion of multi-omics data from glioblastoma (GBM). The analysis shows that MultiSimNeNc outperforms several state-of-the-art module identification algorithms in identification accuracy, which is an effective method for understanding biomolecular mechanisms of pathogenesis from a module-level perspective.
The debate over neurotransmitter interaction in aspartame usage
2018, Journal of Clinical Neuroscience
Aspartame (NutraSweet®, Equal®) is a widely used artificial sweetener, has been reported to be accountable for neurological and behavioural disturbances in people. Upon ingestion, aspartame is hydrolyzed in gut and provides its metabolite; such as essential amino acid phenylalanine (Phy) (50%), aspartic acid (40%), and methanol (10%). Altered brain neurochemical compositions [such as dopamine (DA), norepinephrine (NE), and serotonin (5-HT)] have long been a concern and being involved in observed neurophysiological symptom (such as headaches, memory loss, mood changes, as well as depression) in aspartame consumers. Aspartames might act as chemical stressor through increasing plasma cortisol level. Aspartame consumption similarly altered gut microbiota. Taken together all this factors, we reviewed to search for convincing evidence, in what manner aspartame metabolites, stress hormones (cortisol), and gut dysbiosisis involved in altering brain neurochemical composition. We concluded that aspartame metabolite; mainly Phy and its interaction with neurotransmitter and aspartic acid by acting as excitatory neurotransmitter causes this pattern of impairments. Along with elevated cortisol and gut dysbiosis via interactions with different biogenic amine may also have additional impact to modulate neuronal signaling lead to neurobiological impairments. Hence ongoing research is instantly needed to understand the specific roles of aspartame metabolite, elevated cortisol, and gut dysbiosis with emerging neurophysiological symptom in aspartame consumers to improve healthy life in its consumers.
The Evolving Landscape of Brain Metastasis
2018, Trends in Cancer
Metastasis, involving the spread of systemic cancer to the brain, results in neurologic disability and death. Current treatments are largely palliative in nature; improved therapeutic approaches represent an unmet clinical need. However, recent experimental and clinical advances challenge the bleak long-term outcome of this disease. Encompassing key recent findings in epidemiology, genetics, microenvironment, leptomeningeal disease, neurocognition, targeted therapy, immunotherapy, and prophylaxis, we review preclinical and clinical studies to provide a comprehensive picture of contemporary research and the management of secondary brain tumors.
Time-dependent impact of glutamatergic modulators on the promnesiant effect of 5-HT<inf>6</inf>R blockade on mice recognition memory
2017, Pharmacological Research
Citation Excerpt :
Various hypotheses can explain this unexpected result. First, NMDAR overactivation (caused by high extracellular glutamate levels) is known to have deleterious or even excitotoxic effects [45]. The increase in glutamate levels elicited by the blockade of 5-HT6R is not supposed to raise toxic levels by itself.
Selective antagonists at serotonin 5-HT₆ receptors (5-HT₆R) improve memory performance in rodents and are currently under clinical investigations. If blockade of 5-HT₆R is known to increase glutamate release, only two studies have so far demonstrated an interaction between 5-HT₆R and glutamate transmission, but both, using the non-competitive NMDA antagonist MK-801, insensitive to variations of glutamate concentrations. In a place recognition task, we investigated here in mice the role of glutamate transmission in the beneficial effects of 5-HT₆R blockade (SB-271046). Through the use of increasing intervals (2, 4 and 6 h) between acquisition and retrieval, we investigated the time-dependent impact of two different glutamatergic modulators. NMDAR-dependant glutamate transmission (NMDA Receptors) was either blocked by the competitive antagonist at NMDAR, CGS 19755, or potentiated by the glycine transporter type 1 (GlyT1) inhibitor, NFPS. Results showed that neither SB-271046, nor CGS 19755, nor NFPS, alter behavioural performances after short intervals, i.e. when control mice displayed significant memory performances (2 h and 4 h) (respectively 10, 3, and 0.625 mg.kg⁻¹). Conversely, with the 6h-interval, a situation in which spontaneous forgetting is observed in control mice, SB-271046 improved recognition memory performances. This beneficial effect was prevented when co-administered with either CGS 19755 or NFPS, which themselves had no effect. Interestingly, a dose-dependent effect was observed with NFPS, with promnesic effect observed at lower dose (0.156 mg.kg⁻¹) when administrated alone, whereas it did no modify promnesic effect of SB-271046. These results demonstrate that promnesiant effect induced by 5-HT₆R blockade is sensitive to the competitive blockade of NMDAR and underline the need of a fine adjustment of the inhibition of GlyT1. Overall, our findings support the idea of a complex crosstalk between serotonergic and glutamatergic systems in the promnesic properties of 5-HT₆R antagonists.
Calcium in the pathomechanism of amyotrophic lateral sclerosis – Taking center stage?
2017, Biochemical and Biophysical Research Communications
Amyotrophic lateral sclerosis is an incurable, relentlessly progressive disease primarily affecting motor neurons. The cause of the disease, except for the mutations identified in a small fraction of patients, is unknown. The major mechanisms contributing to the degeneration of motor neurons have already been disclosed and characterized, including excitotoxicity, oxidative stress, mitochondrial dysfunction, and immune/inflammatory processes. During the progression of the disease these toxic processes are not discrete, but each facilitates the deleterious effect of the other. However, due to their common reciprocal calcium dependence, calcium ions may act as a common denominator and through a positive feedback loop may combine the individual pathological processes into a unified escalating mechanism of neuronal destruction. This mini-review provides an overview of the mutual calcium dependence of the major toxic mechanisms associated with amyotrophic lateral sclerosis.
Physicochemical Properties for Potential Alzheimer's Disease Drugs
2017, Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease
Current methods for the treatment of Alzheimer's disease (AD) provide temporary relief, increase cognitive function, but do not inhibit the long-term progression of this disorder. Moreover, these treatments have a modest effect on the progression of AD from mild cognitive impairment to disabling dementia and death. Therefore there is an urgent need to develop strategies to improve the efficacy, bioavailability, transport across the blood–brain barrier, and subsequently to limit the adverse effects of pharmaceutical compounds for the treatment of AD. Appropriate physicochemical properties will afford adequate CNS bioavailability and access to the active site. In this review, we seek to evaluate the importance of various structural modifications of compounds, how the physicochemical properties of these compounds relate to their activities, which can lead to potent compounds that may prevent or reverse the progression of AD.

View all citing articles on Scopus

View full text

Trends in Neurosciences

ReviewExcitotoxity and the NMDA receptor

Abstract

Brain Res.

Neurosci. Lett.

Neuroscience

Neuroscience

Neuroscience

Brain Res. Bull.

Lancet

AMA Arch. Ophthalmol.

Science

Exp. Brain Res.

Neurosci. Lett.

J. Neurosci.

J. Neurosci.

J. Neurosci.

Neurosci. Lett.

Nature

Am. J. Pathol.

Soc. Neurosci. Abstr.

Review
Excitotoxity and the NMDA receptor